NLRP3 and pulmonary fibrosis: Thus, using this model, in this study we investigated the effects of NXC736 on the regulation of EMT and pulmonary fibrosis by inhibiting the signaling pathways of NLRP3 and IL-1β in RILF, with the goal of assessing its potential as a pulmonary fibrosis inhibitory drug.